sulpiride has been researched along with ondansetron in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (10.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (10.00) | 29.6817 |
2010's | 8 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Costall, B; Domeney, AM; Naylor, RJ; Tyers, MB | 1 |
Hema, T; Maran, S; Subhashini, G | 1 |
Christensen, TB; Daugaard, G; Fox, GM; Herrstedt, J; Holmskov, K; Molassiotis, A; Summers, Y; Taylor, PD | 1 |
Abbasi-Maleki, S; Mesbahzadeh, B; Moradi-Kor, N | 1 |
1 trial(s) available for sulpiride and ondansetron
Article | Year |
---|---|
Amisulpride in the prevention of nausea and vomiting induced by cisplatin-based chemotherapy: a dose-escalation study.
Topics: Adult; Aged; Amisulpride; Antiemetics; Cisplatin; Dopamine Antagonists; Female; Humans; Male; Middle Aged; Nausea; Ondansetron; Remission Induction; Serotonin 5-HT3 Receptor Antagonists; Sulpiride; Vomiting | 2018 |
9 other study(ies) available for sulpiride and ondansetron
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain.
Topics: Amygdala; Animals; Behavior, Animal; Brain; Callitrichinae; Fluphenazine; Imidazoles; Injections; Limbic System; Male; Motor Activity; Nucleus Accumbens; Ondansetron; Rats; Rats, Inbred Strains; Receptors, Dopamine; Serotonin Antagonists; Species Specificity; Stereotaxic Techniques; Sulpiride | 1987 |
Adjunctive ondansetron in schizophrenia--A pilot study.
Topics: Adult; Amisulpride; Antipsychotic Agents; Clozapine; Drug Therapy, Combination; Feasibility Studies; Humans; Ondansetron; Pilot Projects; Schizophrenia; Sulpiride; Treatment Outcome | 2016 |
Zinc enhances the expression of morphine-induced conditioned place preference through dopaminergic and serotonergic systems.
Topics: Animals; Benzazepines; Conditioning, Psychological; Dopamine Antagonists; Haloperidol; Ketanserin; Male; Morphine; Ondansetron; Piperazines; Rats; Rats, Wistar; Reward; Serotonin Antagonists; Sulpiride; Zinc | 2019 |